Poxel SA: Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2022

POXEL SA (Euronext: POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic

Related Keywords

China ,Boston ,Massachusetts ,United States ,Taiwan ,Japan ,Tokyo ,South Korea ,France ,French ,Arthur Rouill ,Sumitomo Pharma , ,Annual General Meeting ,Registration Document ,French Commercial ,General Meeting ,Annual General Meeting Documents ,Japan Poxel ,Southeast Asian ,Euronext Paris ,Relations Communication Senior Director ,Vice President ,Investor Relations Communication ,Poxel ,Nnounces ,Notice ,Nnual ,Eneral ,Meeting ,Held ,Pune ,022 ,